查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1922999

塑胶血袋市场按材料类型、产品类型、灭菌方法、应用和最终用户划分－2026-2032年全球预测

Plastic Blood Bag Market by Material Type, Product Type, Sterilization Method, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，塑胶血袋市场价值将达到 30.1 亿美元，到 2026 年将成长至 31.8 亿美元，到 2032 年将达到 45.8 亿美元，年复合成长率为 6.19%。

关键市场统计数据
基准年 2025 30.1亿美元
预计年份：2026年 31.8亿美元
预测年份 2032 45.8亿美元
复合年增长率 (%) 6.19%

本书权威地介绍了现代塑胶血袋研发的临床需求、材料演变、监管限制和永续性因素。

塑胶血袋的研发和应用体现了临床需求、材料科学和法律规范三者共同作用的结果，这些因素共同塑造了现代输血体系。血袋是至关重要的医疗医疗设备，必须确保血液和血液成分的无菌采集、安全储存和高效输注，同时在规定的保质期内保持细胞完整性和生化稳定性。近年来，聚合物化学和製造技术的进步使得传统材料的替代方案得以出现，进而推动了医院、血库和诊所供应商关係和采购方式的改变。

材料创新、灭菌策略和供应链本地化如何协同重塑产品设计、检验时间表和商业性定位

塑胶血袋产业正经历材料创新、灭菌方法和供应链重组三方面的多重变化。首先，材料正从传统的聚氯乙烯（PVC）配方转向非PVC替代品和先进聚烯的混合物，这些混合物具有不同的机械性能和环境特性。这项转变的驱动力既来自对添加剂化学品日益严格的监管，也来自企业永续性目标的推动，迫使製造商重新评估其配方平台，并检验用于血液接触应用的新型聚合物混合物。

评估近期美国关税对筹资策略、供应商整合、库存管理实务和生产本地化的累积影响

近期源自美国的贸易措施和关税对包括塑胶血袋在内的全球医用塑胶及成品医疗设备供应链产生了显着的累积影响。这些关税影响了进口原材料（例如特殊树脂和添加剂）的成本结构，迫使加工商和成品製造商调整价格并重新谈判供应商合约。为此，许多製造商正在重新审视其采购管道，尽可能转向国内供应商或免税供应商，并加快替代树脂系列的认证，以减少对特定税号的依赖。

详细的細項分析揭示了材料选择、包装袋结构、最终用户环境、应用需求和灭菌方法如何相互作用，从而指南策略制定。

细緻的市场区隔架构揭示了产品策略和商业化的关键要素，涵盖材料、产品组合、最终用户、应用和灭菌方法等多个维度。基于材料类型的市场分析区分了非PVC和PVC两种选择，其中非PVC类别进一步细分为生物基聚合物和聚烯。聚烯子类别则根据HDPE和LDPE的不同类型进行分析。这些材料差异显着影响生物相容性、阻隔性能、柔软性以及与灭菌方法的兼容性。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和需求模式存在差异，这将影响产品优先顺序和供应策略。

区域趋势造就了不同的需求模式、法规环境和供应链行为，进而影响製造商确定市场优先事项和分配资源的方式。在美洲，完善的输血基础设施和集中化的血液服务推动了对成熟产品形式的稳定需求，同时促进了创新，以降低生命週期成本并简化物流。该地区的监管路径和报销框架也提供了奖励，鼓励建立长期的供应商关係并检验供应的连续性。

材料智慧财产权、灭菌验证、生产规模和策略伙伴关係关係等竞争优势如何影响供应商选择和商业性槓桿作用

塑胶血袋市场的竞争格局由在材料创新、生产规模、灭菌技术和临床分销管道方面具有优势的企业主导。拥有整合聚合物供应链和医用级材料检验经验的现有企业在控制可萃取物和可浸出物风险方面保持优势。同时，灵活的专业製造商透过提供差异化的血袋结构并快速获得非PVC配方认证，正在开拓市场机会。拥有无菌生产环境和检验供应链管理的契约製造製造商正在赢得寻求外包资本密集型业务的企业的青睐，建立合作伙伴关係。

实际有效的领导策略，旨在加强材料多样化、灭菌验证、供应链韧性和永续性，从而建立竞争优势。

行业领导者必须采取多管齐下的策略，以应对当前的挑战并掌握塑胶血袋领域的新机会。首先，投资建构多元化的材料平台，以减少对单一来源的依赖。验证生物基聚合物和聚烯替代品与传统配方的兼容性，以确保临床应用的连续性并支持永续性措施。儘早投资于可萃取物和可浸出物检验，将有助于与监管机构进行沟通，并加速医院层面的应用。

采用严谨的混合方法研究途径，结合相关人员访谈、监管审查、技术文献和情境压力测试，确保研究结果具有可操作性和检验。

本执行摘要的调查方法结合了结构化的初步研究和严谨的二次检验，以确保其稳健性和实用性。主要研究结果来自对临床采购、血液服务运作、生产品质和法规事务等相关人员的访谈，从而提供了关于材料性能、灭菌操作和采购标准的第一手观点。这些定性研究旨在突显跨部门协作，并揭示营运限制和实施障碍。

整合策略重点，将材料创新、检验严谨性和供应链韧性结合，以确保临床可接受性和商业性成功。

总之，塑胶血袋产业正处于战略转折点，材料创新、灭菌策略、区域供应趋势和政策行动的交汇点正在重新定义竞争优势。积极拓展材料平台、协调灭菌和检验策略并增强供应链韧性的企业，将更有能力满足不断变化的临床需求和医疗服务提供者的期望。同时，不同地区在监管严格程度和采购惯例的差异，将需要企业制定量身定制的产品定位和市场进入策略。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依材质类型分類的塑胶血袋市场

  • 不含聚氯乙烯
    • 生物基聚合物
    • 聚烯
      • HDPE
      • LDPE
  • PVC

9. 按产品类型分類的塑胶血袋市场

  • 双人房
  • 单室
  • 三重房

第十章 依灭菌方法分類的塑胶血袋市场

  • 环氧乙烷灭菌
  • 伽玛射线灭菌

第十一章 按应用分類的塑胶血袋市场

  • 血液收集
  • 贮存
  • 输血

第十二章 按终端用户分類的塑胶血袋市场

  • 血库
  • 诊所
  • 医院

第十三章 各地区塑胶血袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 塑胶血袋市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国塑胶血袋市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国塑胶血袋市场

第十七章：中国的塑胶血袋市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3S Corporation
  • AdvaCare Pharma
  • B. Braun Melsungen AG
  • BL Life Sciences Private Limited
  • Cellbios Healthcare And Lifesciences Pvt Ltd
  • Demophorius Limited
  • Eastern Medikit Ltd.
  • Fresenius SE & Co. KGaA
  • Futura Surgical Pvt. Ltd.
  • Global Medikit Ltd.
  • Grifols, SA
  • Haemonetics Corporation
  • HLL Lifecare Limited
  • J. Mitra & Co. Private Limited
  • Jiaxing Tianhe Pharmaceutical Co., Ltd.
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Lars Medicare Private Ltd.
  • Maco Pharma International GmbH
  • Medtrue Enterprise Co. Ltd.
  • Mitra Industries Private Limited
  • Poly Medicure Limited
  • Terumo Corporation
Product Code: MRR-867BED9A9EB5

The Plastic Blood Bag Market was valued at USD 3.01 billion in 2025 and is projected to grow to USD 3.18 billion in 2026, with a CAGR of 6.19%, reaching USD 4.58 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.01 billion
Estimated Year [2026] USD 3.18 billion
Forecast Year [2032] USD 4.58 billion
CAGR (%) 6.19%

An authoritative introduction framing the clinical imperatives, materials evolution, regulatory constraints, and sustainability factors defining modern plastic blood bag development

The development and use of plastic blood bags represent a convergence of clinical necessity, materials science, and regulatory oversight that together shape modern transfusion systems. Blood bags are critical medical devices that must ensure the sterile collection, safe storage, and efficient transfusion of blood and blood components while maintaining cellular integrity and biochemical stability over established hold times. In recent years, advances in polymer chemistry and manufacturing have introduced alternatives to legacy materials, prompting shifts in supplier relationships and procurement criteria across hospitals, blood banks, and clinics.

Beyond raw functionality, decisions about blood bag design increasingly reflect broader institutional priorities, including sustainability targets, single-use policy considerations, and lifecycle cost management. Regulatory frameworks continue to tighten around biocompatibility, extractables and leachables, and sterilization validation, thereby affecting design timelines and supplier selection. As a result, stakeholders from R&D to procurement and regulatory affairs must balance clinical performance with manufacturability, sterilization compatibility, and environmental impact when evaluating next-generation products.

This introduction sets the stage for a focused exploration of the forces reconfiguring the plastic blood bag landscape. Subsequent sections will examine disruptive shifts in materials and manufacturing, policy impacts such as tariffs and trade measures, detailed segmentation insights, regional variations, competitive behaviors, and practical recommendations for industry leaders navigating this complex environment.

How material innovation, sterilization strategy, and supply chain regionalization are jointly reshaping product design, validation timelines, and commercial positioning

The plastic blood bag landscape is undergoing multiple transformative shifts that intersect at materials innovation, sterilization practices, and supply chain reconfiguration. First, material evolution is moving away from traditional polyvinyl chloride formulations toward a mix of non-PVC alternatives and advanced polyolefins that offer different mechanical properties and environmental profiles. This transition is driven by both regulatory scrutiny over additive chemistries and institutional sustainability goals, and it is prompting manufacturers to reassess formulation platforms and validate new polymer blends for blood contact applications.

Second, sterilization technologies are influencing product design choices and logistics. Ethylene oxide sterilization remains widespread for its compatibility with many polymers and complex assemblies, while gamma sterilization offers rapid throughput and penetrative efficacy at different stages of the supply chain. Manufacturers and healthcare facilities are increasingly optimizing sterilization strategy alongside packaging and supply decisions to reduce cycle times and preserve product integrity.

Third, supply chain dynamics have shifted toward regionalization and strategic sourcing. Disruption risk, lead-time variability, and raw material concentration have encouraged buyers to diversify supplier bases and to consider nearer-sourced production to mitigate geopolitical and logistical vulnerabilities. These shifts are reinforcing the importance of integrated product stewardship and cross-functional coordination between regulatory, sourcing, and commercial teams.

Together, these transformative shifts are reshaping product roadmaps, quality assurance protocols, and commercial positioning, requiring companies to invest in material science capabilities, sterilization validation pathways, and resilient sourcing strategies.

Assessing the cumulative repercussions of recent United States tariff measures on procurement strategies, supplier consolidation, inventory practices, and production localization

Recent trade measures and tariffs originating from the United States have had a tangible cumulative impact on the global supply chain for medical plastics and finished medical devices, including plastic blood bags. Tariffs affect the cost structure of imported raw materials such as specialty resins and additives, which in turn pressures converters and finished-goods manufacturers to reprice or renegotiate supplier agreements. In response, many manufacturers have re-evaluated sourcing footprints, shifting procurement toward domestic or tariff-exempt suppliers where possible, and accelerating qualification of alternative resin families to reduce exposure to specific tariff lines.

Beyond immediate cost considerations, tariffs have influenced strategic decisions regarding inventory management and production location. Companies have adjusted safety stock levels and considered localized manufacturing to avoid repetitive tariff impacts and to shorten supplier lead times. These changes have labor and capital implications, as bringing production closer to end markets can require new investments in tooling, validation, and regulatory submissions.

Another important effect has been on supplier consolidation dynamics. Where tariffs increase the total landed cost of inputs, smaller suppliers may find it harder to compete, prompting consolidation or exit from specific product lines. Conversely, larger integrated players with diversified feedstock access can capture incremental business by offering more stable pricing and continuity of supply.

Taken together, the cumulative impact of tariff measures has reinforced the need for scenario planning, multi-source qualification, and a stronger emphasis on contractual flexibility and supply continuity to ensure uninterrupted delivery of sterile blood collection and storage products.

Deep segmentation analysis revealing how material choices, bag architecture, end-user settings, application demands, and sterilization approaches intersect to inform strategy

A nuanced segmentation framework reveals important levers for product strategy and commercialization across material, product configuration, end user, application, and sterilization method dimensions. Based on Material Type, market analysis differentiates between Non-PVC and PVC options, with the Non-PVC category further subdivided into Bio-Based Polymers and Polyolefin, and the Polyolefin subgroup analyzed across HDPE and LDPE variants. These material distinctions materially influence biocompatibility profiles, barrier properties, flexibility, and compatibility with sterilization modalities.

Based on Product Type, the landscape is organized around single chamber, double chamber, and triple chamber bag architectures, each addressing different clinical workflows and component separation needs; selection among these types depends on clinical protocols, processing equipment compatibility, and component yield objectives. Based on End User, the market is evaluated across Blood Banks, Clinics, and Hospitals, recognizing that purchasing criteria and usage patterns vary significantly between centralized blood services and decentralized clinical settings. Based on Application, blood bags are assessed for their suitability in Blood Collection, Storage, and Transfusion use cases, with design trade-offs made to prioritize collection efficiency, preservative compatibility, and transfusion safety.

Based on Sterilization Method, the analysis contrasts Ethylene Oxide Sterilization with Gamma Sterilization, acknowledging that sterilization choice affects material selection, packaging decisions, and validation complexity. Integrated consideration of these segmentation axes provides manufacturers and purchasers with a clearer view of where investments in material science, device architecture, and process validation will yield the greatest clinical and commercial returns. This combined segmentation approach also facilitates targeted product positioning and regulatory strategy that aligns with specific end-user needs.

Regional dynamics and differentiated demand patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine product prioritization and supply strategies

Regional dynamics create differentiated demand patterns, regulatory environments, and supply chain behaviors that shape how manufacturers prioritize markets and allocate resources. In the Americas, established transfusion infrastructures and centralized blood services drive consistent demand for proven product formats while encouraging innovation that lowers total lifecycle cost and streamlines logistics. Regulatory pathways and reimbursement frameworks in this region also incentivize durable vendor relationships and validated supply continuity.

In Europe, Middle East & Africa, diverse regulatory regimes and varying healthcare investment levels create opportunities for modular product offerings and regionally tailored sterilization strategies. Sustainability initiatives and regulatory scrutiny over materials are particularly pronounced in parts of Europe, prompting accelerated evaluation of non-PVC materials and lifecycle assessments. In parts of the Middle East and Africa, demand is driven by investments in hospital capacity expansion and by programs aimed at strengthening national blood services, which creates space for both established suppliers and local manufacturers.

In Asia-Pacific, a mix of mature markets and rapidly developing healthcare systems produces heterogenous adoption curves for advanced bag architectures and alternative materials. Fast-growing private healthcare sectors and expanding blood services drive demand for scalable production and competitive pricing, while regional manufacturing hubs provide opportunities for near-market production and export. Across all regions, local regulatory harmonization efforts and regional supply chain resilience strategies alter go-to-market sequencing and the prioritization of validation activities.

How competitive advantages emerge from material IP, sterilization validation, manufacturing scale, and strategic partnerships that shape supplier selection and commercial leverage

Competitive dynamics in the plastic blood bag landscape are shaped by players with strengths in material innovation, manufacturing scale, sterilization expertise, or clinical distribution channels. Market incumbents with integrated polymer supply chains and experience in medical-grade material validation retain advantages in managing extractables and leachables risk, while nimble specialty manufacturers find openings by offering differentiated bag architectures or by rapidly qualifying non-PVC formulations. Contract manufacturing organizations that combine sterile production environments with validated supply chain controls attract partnerships from firms seeking to outsource capital-intensive operations.

Strategic moves such as vertical integration, strategic partnerships with polymer innovators, and targeted investments in sterilization and packaging validation are common among firms aiming to defend or expand their positions. Additionally, cross-border alliances and toll-manufacturing arrangements help balance capacity constraints and regional demand variability. Private label and hospital group procurement initiatives are altering commercial negotiations, increasing the importance of demonstrable quality systems, consistent lot-to-lot performance, and transparent supply continuity plans.

Intellectual property around bio-based polymer blends, additive-free stabilizing technologies, and proprietary multi-chamber welding techniques also constitute competitive differentiators. Companies that combine technical IP with strong regulatory track records and extensive quality documentation can shorten qualification timelines for large institutional buyers. Overall, success favors organizations that can align R&D, quality, and commercial teams to meet evolving clinical, regulatory, and sustainability requirements.

Practical, high-impact actions for leaders to strengthen material diversification, sterilization validation, supply resilience, and sustainability credentials for competitive advantage

Industry leaders must adopt a multi-faceted approach to navigate current disruptions and capitalize on emerging opportunities in the plastic blood bag space. First, invest in diversified material platforms to reduce single-source exposure: validate bio-based polymers and polyolefin alternatives in parallel with legacy formulations to provide clinical continuity and to support sustainability commitments. Early investment in extractables and leachables studies will smooth regulatory engagements and accelerate hospital-level adoption.

Second, align sterilization strategy with material choices and logistics: co-develop validation protocols with sterilization providers and consider dual-compatibility where feasible to increase flexibility across production sites. Third, strengthen supplier networks and contractual terms to improve resilience: qualify multiple resin suppliers across geographies, negotiate tariff contingencies, and build collaborative demand forecasting with key buyers to stabilize production planning. Fourth, prioritize modular product design and documentation readiness: produce technical files and regulatory dossiers that allow rapid adaptation to regional regulatory requirements and hospital procurement standards.

Finally, integrate sustainability and lifecycle perspectives into product value propositions: quantify waste reduction opportunities, evaluate reusable ancillary components where clinically appropriate, and communicate validated environmental metrics to procurement stakeholders. By executing these actions, leaders can reduce operational risk, accelerate market acceptance of new materials, and create defensible differentiation in a crowded and evolving field.

A rigorous mixed-methods research approach combining stakeholder interviews, regulatory review, technical literature, and scenario stress-testing to ensure actionable and validated findings

The research methodology underpinning this executive summary combines structured primary inquiry with rigorous secondary validation to ensure robustness and practical relevance. Primary insights were derived from interviews with stakeholders across clinical procurement, blood service operations, manufacturing quality, and regulatory affairs, providing first-hand perspectives on material performance, sterilization practices, and purchasing criteria. These qualitative engagements were conducted with a focus on cross-functional alignment to surface operational constraints and adoption barriers.

Secondary validation involved systematic review of open regulatory guidance, standards applicable to blood-contact devices, and peer-reviewed literature on polymer biocompatibility and sterilization compatibility. Data triangulation reconciled divergent inputs and highlighted consistent themes such as the need for multi-source qualification and the impact of sterilization choices on material selection. Attention was paid to real-world operational constraints, including supply chain lead times and validation timelines, to ensure recommendations were actionable for manufacturers and purchasers.

Throughout the research process, findings were stress-tested against alternative scenarios including shifts in tariff policy, accelerated adoption of non-PVC materials, and regional manufacturing expansion, yielding a set of prioritized implications and recommended actions that align with both regulatory and clinical imperatives.

Concluding synthesis of strategic priorities that reconcile materials innovation, validation rigor, and supply resilience to ensure clinical acceptance and commercial success

In conclusion, the plastic blood bag sector is at a strategic inflection point where material innovation, sterilization strategy, regional supply dynamics, and policy measures intersect to redefine competitive advantage. Organizations that proactively diversify material platforms, align sterilization and validation strategies, and shore up supply chain resilience will be best positioned to meet evolving clinical requirements and institutional expectations. At the same time, regional nuances in regulatory rigor and procurement practices necessitate tailored approaches to product positioning and market entry.

Key takeaways emphasize the importance of early extractables and leachables work, multi-source qualification of critical inputs, and the integration of sustainability metrics into commercial narratives. Companies that couple technical competence with transparent quality systems and flexible contractual models can capture opportunities created by changing procurement patterns and tariff-induced sourcing shifts. The path forward demands coordinated action across R&D, quality, manufacturing, and commercial teams to translate technical advances into clinically accepted, commercially viable products.

Overall, a disciplined, cross-functional response that balances innovation with regulatory and supply certainty will enable stakeholders to deliver safe, effective, and sustainable blood collection and storage solutions in a rapidly evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Plastic Blood Bag Market, by Material Type

  • 8.1. Non-PVC
    • 8.1.1. Bio-Based Polymers
    • 8.1.2. Polyolefin
      • 8.1.2.1. HDPE
      • 8.1.2.2. LDPE
  • 8.2. PVC

9. Plastic Blood Bag Market, by Product Type

  • 9.1. Double Chamber
  • 9.2. Single Chamber
  • 9.3. Triple Chamber

10. Plastic Blood Bag Market, by Sterilization Method

  • 10.1. Ethylene Oxide Sterilization
  • 10.2. Gamma Sterilization

11. Plastic Blood Bag Market, by Application

  • 11.1. Blood Collection
  • 11.2. Storage
  • 11.3. Transfusion

12. Plastic Blood Bag Market, by End User

  • 12.1. Blood Banks
  • 12.2. Clinics
  • 12.3. Hospitals

13. Plastic Blood Bag Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Plastic Blood Bag Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Plastic Blood Bag Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Plastic Blood Bag Market

17. China Plastic Blood Bag Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3S Corporation
  • 18.6. AdvaCare Pharma
  • 18.7. B. Braun Melsungen AG
  • 18.8. B.L. Life Sciences Private Limited
  • 18.9. Cellbios Healthcare And Lifesciences Pvt Ltd
  • 18.10. Demophorius Limited
  • 18.11. Eastern Medikit Ltd.
  • 18.12. Fresenius SE & Co. KGaA
  • 18.13. Futura Surgical Pvt. Ltd.
  • 18.14. Global Medikit Ltd.
  • 18.15. Grifols, S.A.
  • 18.16. Haemonetics Corporation
  • 18.17. HLL Lifecare Limited
  • 18.18. J. Mitra & Co. Private Limited
  • 18.19. Jiaxing Tianhe Pharmaceutical Co., Ltd.
  • 18.20. JMS Co., Ltd.
  • 18.21. Kawasumi Laboratories, Inc.
  • 18.22. Lars Medicare Private Ltd.
  • 18.23. Maco Pharma International GmbH
  • 18.24. Medtrue Enterprise Co. Ltd.
  • 18.25. Mitra Industries Private Limited
  • 18.26. Poly Medicure Limited
  • 18.27. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PLASTIC BLOOD BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PLASTIC BLOOD BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY HDPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY HDPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY HDPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY LDPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY LDPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY LDPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS PLASTIC BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GCC PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 137. GCC PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 138. GCC PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 140. GCC PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. G7 PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 161. G7 PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 162. G7 PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 164. G7 PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. NATO PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 169. NATO PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 170. NATO PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 172. NATO PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA PLASTIC BLOOD BAG MARKET SIZE, BY POLYOLEFIN, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA PLASTIC BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)